Fulcrum Therapeutics
Price & Volume
Stats
See moreOpen | $4.44 |
Previous Close | $4.38 |
Day Range | $4.44-$5.12 |
52W Range | $2.31-$10.13 |
Market Cap | $236.4M |
Shares Short | 3M |
Financials
See moreRevenue (12 Mos) | $80M |
Revenue Growth (YoY) | -100% |
Gross Profit (12 Mos) | $16.6M |
Diluted EPS | -$0.16 |
News
See moreYahoo Finance • 21 days ago
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance • 2 months ago
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Fourth Quarter and Full Year 2024
Yahoo Finance • 2 months ago
Fulcrum Therapeutics to Host Fourth Quarter and Full Year 2024 Financial Results Conference Call and Webcast on Tuesday, February 25, 2025, at 8:00 a.m. ET
Yahoo Finance • 3 months ago
Fulcrum Therapeutics to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference
About
CEO | Mr. Alexander C. Sapir |
Address | 26 Landsdowne Street, Cambridge, MA, United States, 02139 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 45 |
